Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1716662

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy: Standards
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what progress they have made towards ensuring that people with cancer who require radiotherapy treatment can start treatment within their target of 31 days.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4473
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>We are seeing continued high levels of urgent cancer referrals, with over 12,000 urgent referrals seen for suspected cancer per working day in March 2024, compared to approximately 9,000 in March 2019. In March 2023, 89.7% of patients received a first or subsequent radiotherapy treatment within 31 days of a decision to treat, which is 0.6% higher than last year. From March 2023/24, 127,336 people received a first or subsequent radiotherapy treatment, which is 1,359 more than the previous year.</p><p>The Government continues to work with NHS England on implementing the Delivery plan for tackling the COVID-19 backlog of elective care, and plans to spend more than £8 billion from 2022/23 to 2024/25 to help drive up and protect elective activity, including cancer diagnosis and treatment activity.</p><p>We are building our cancer workforce. In January 2024 there were over 35,200 full-time equivalent (FTE) staff in the cancer workforce, an increase of over 13,300, or 60.7% since January 2010. This includes over 8,100 FTE consultants in January 2024, an increase of over 3,300, or 69.6% since January 2010.</p><p>Since 2016, the Department has invested £162 million into cutting-edge radiotherapy equipment to replace or upgrade more than 100 radiotherapy treatment machines, so we can deliver the best possible outcomes for patients. From April 2022, the responsibility for investing in new radiotherapy machines sits with local systems.</p> answering member printed Lord Markham question first answered 20/05/2024 14:54:55 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1716663

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy: Costs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the HERO (Health Economics in Radiation Oncology) study published by the UK Radiotherapy Board, which is the first report to estimate the cost of radiotherapy services in England.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4474
answer	answer is ministerial correction date of answer 16/05/2024 answer text <p>Since 2016, there has been significant investment in radiotherapy equipment, so that every radiotherapy provider had access to modern, cutting-edge radiotherapy equipment, enabling the rollout of new techniques like stereotactic ablative radiotherapy. The total central investment made between 2016 and 2021 was £162 million, and enabled the replacement or upgrade of approximately 100 radiotherapy treatment machines. This is investment on top of that committed by National Health Service trusts, either from their own capital budgets or via donations. From April 2022, the responsibility for investing in new radiotherapy machines sits with local systems. This is supported by the 2021 spending review, which set aside £12 billion in operational capital for the NHS.</p> answering member printed Lord Markham grouped question UIN HL4475 question first answered 16/05/2024 16:30:12 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1716664

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy: Costs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the current cost of radiotherapy services in England, following the publication of the HERO (Health Economics in Radiation Oncology) report by the UK Radiotherapy Board.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4475
answer	answer is ministerial correction date of answer 16/05/2024 answer text <p>Since 2016, there has been significant investment in radiotherapy equipment, so that every radiotherapy provider had access to modern, cutting-edge radiotherapy equipment, enabling the rollout of new techniques like stereotactic ablative radiotherapy. The total central investment made between 2016 and 2021 was £162 million, and enabled the replacement or upgrade of approximately 100 radiotherapy treatment machines. This is investment on top of that committed by National Health Service trusts, either from their own capital budgets or via donations. From April 2022, the responsibility for investing in new radiotherapy machines sits with local systems. This is supported by the 2021 spending review, which set aside £12 billion in operational capital for the NHS.</p> answering member printed Lord Markham grouped question UIN HL4474 question first answered 16/05/2024 16:30:12 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1715969

registered interest
date	07/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy: Waiting Lists
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the proportion of cancer patients currently waiting more than 31 days for radiotherapy treatment.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4423
answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>According to the latest data, of those 10,328 cancer patients referred for first or subsequent treatment for radiotherapy in March 2024, 89.7% were treated within 31 days. The proportion of patients waiting more than 31 days for radiotherapy treatment in March 2024 was therefore 10.3%. This has decreased by 4.5% since January 2024.</p><p>We are aware of regional disparities in wait times for cancer treatment through NHS England’s data, and are considering the findings made by the Royal College of Radiologists. Tackling inequalities in outcomes, experience, and access of cancer diagnostics, including regional disparities, is a key focus of the Government. NHS England has commissioned six new cancer clinical audits in breast cancer, both primary and metastatic, as well as ovarian, pancreatic, non-Hodgkin lymphoma, and kidney cancer. These will provide timely evidence for cancer service providers of where patterns of care in England may vary, increase the consistency of access to treatments, and help stimulate improvements in cancer treatments and outcomes for patients. The first outcomes of these audits are expected in September 2024.</p><p>The Department is working closely with NHS England to make sure we have the right workforce with the right skills up and down the country. In 2023/24, NHS England invested an additional £50 million to increase the number of cancer and diagnostic specialists.</p><p>The Government is also backing the NHS Long Term Workforce Plan, with over £2.4 billion over the next five years to fund additional education and training places. The plan sets out an aim to double the number of medical school places in England to 15,000 places a year by 2031/32, and to work towards this expansion by increasing places by a third, to 10,000 a year, by 2028/29.</p><p>We are building our cancer workforce. In January 2024 there were over 35,200 full-time equivalent (FTE) staff in the cancer workforce, an increase of over 13,300, or 60.7% since January 2010. Regarding clinical oncology specifically, as of January 2024, there are currently over 1,600 FTE doctors working in the speciality of clinical oncology in National Health Service trusts and other core organisations in England. This is over 30, or 2.2%, more than last year, over 300, or 27.7%, more than 2019, and over 600, 66.5%, more than in 2010. This includes over 900 FTE consultants. This is over 40, or 5.1%, more than last year, over 100, 22.0%, more than in 2019, and over 400, 80.2%, more than in 2010.</p> answering member printed Lord Markham grouped question UIN HL4424 HL4425 question first answered 13/05/2024 11:23:46 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1715970

registered interest
date	07/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: North East
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of findings from the Royal College of Radiologists, published in May, showing a regional disparity in wait times for cancer treatment in 2023, with 11 per cent of patients in England waiting more than 31 days for treatment after the decision to treat had been confirmed, compared to 19 per cent of patients in the North East and Yorkshire.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4424
answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>According to the latest data, of those 10,328 cancer patients referred for first or subsequent treatment for radiotherapy in March 2024, 89.7% were treated within 31 days. The proportion of patients waiting more than 31 days for radiotherapy treatment in March 2024 was therefore 10.3%. This has decreased by 4.5% since January 2024.</p><p>We are aware of regional disparities in wait times for cancer treatment through NHS England’s data, and are considering the findings made by the Royal College of Radiologists. Tackling inequalities in outcomes, experience, and access of cancer diagnostics, including regional disparities, is a key focus of the Government. NHS England has commissioned six new cancer clinical audits in breast cancer, both primary and metastatic, as well as ovarian, pancreatic, non-Hodgkin lymphoma, and kidney cancer. These will provide timely evidence for cancer service providers of where patterns of care in England may vary, increase the consistency of access to treatments, and help stimulate improvements in cancer treatments and outcomes for patients. The first outcomes of these audits are expected in September 2024.</p><p>The Department is working closely with NHS England to make sure we have the right workforce with the right skills up and down the country. In 2023/24, NHS England invested an additional £50 million to increase the number of cancer and diagnostic specialists.</p><p>The Government is also backing the NHS Long Term Workforce Plan, with over £2.4 billion over the next five years to fund additional education and training places. The plan sets out an aim to double the number of medical school places in England to 15,000 places a year by 2031/32, and to work towards this expansion by increasing places by a third, to 10,000 a year, by 2028/29.</p><p>We are building our cancer workforce. In January 2024 there were over 35,200 full-time equivalent (FTE) staff in the cancer workforce, an increase of over 13,300, or 60.7% since January 2010. Regarding clinical oncology specifically, as of January 2024, there are currently over 1,600 FTE doctors working in the speciality of clinical oncology in National Health Service trusts and other core organisations in England. This is over 30, or 2.2%, more than last year, over 300, or 27.7%, more than 2019, and over 600, 66.5%, more than in 2010. This includes over 900 FTE consultants. This is over 40, or 5.1%, more than last year, over 100, 22.0%, more than in 2019, and over 400, 80.2%, more than in 2010.</p> answering member printed Lord Markham grouped question UIN HL4423 HL4425 question first answered 13/05/2024 11:23:46 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1715971

registered interest
date	07/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy: Staff
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking to ensure that the 15 per cent shortfall in clinical oncologists, as estimated in the Royal College of Radiologists workforce census, does not impact the operational performance of radiotherapy services.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4425
answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>According to the latest data, of those 10,328 cancer patients referred for first or subsequent treatment for radiotherapy in March 2024, 89.7% were treated within 31 days. The proportion of patients waiting more than 31 days for radiotherapy treatment in March 2024 was therefore 10.3%. This has decreased by 4.5% since January 2024.</p><p>We are aware of regional disparities in wait times for cancer treatment through NHS England’s data, and are considering the findings made by the Royal College of Radiologists. Tackling inequalities in outcomes, experience, and access of cancer diagnostics, including regional disparities, is a key focus of the Government. NHS England has commissioned six new cancer clinical audits in breast cancer, both primary and metastatic, as well as ovarian, pancreatic, non-Hodgkin lymphoma, and kidney cancer. These will provide timely evidence for cancer service providers of where patterns of care in England may vary, increase the consistency of access to treatments, and help stimulate improvements in cancer treatments and outcomes for patients. The first outcomes of these audits are expected in September 2024.</p><p>The Department is working closely with NHS England to make sure we have the right workforce with the right skills up and down the country. In 2023/24, NHS England invested an additional £50 million to increase the number of cancer and diagnostic specialists.</p><p>The Government is also backing the NHS Long Term Workforce Plan, with over £2.4 billion over the next five years to fund additional education and training places. The plan sets out an aim to double the number of medical school places in England to 15,000 places a year by 2031/32, and to work towards this expansion by increasing places by a third, to 10,000 a year, by 2028/29.</p><p>We are building our cancer workforce. In January 2024 there were over 35,200 full-time equivalent (FTE) staff in the cancer workforce, an increase of over 13,300, or 60.7% since January 2010. Regarding clinical oncology specifically, as of January 2024, there are currently over 1,600 FTE doctors working in the speciality of clinical oncology in National Health Service trusts and other core organisations in England. This is over 30, or 2.2%, more than last year, over 300, or 27.7%, more than 2019, and over 600, 66.5%, more than in 2010. This includes over 900 FTE consultants. This is over 40, or 5.1%, more than last year, over 100, 22.0%, more than in 2019, and over 400, 80.2%, more than in 2010.</p> answering member printed Lord Markham grouped question UIN HL4423 HL4424 question first answered 13/05/2024 11:23:46 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1715436

registered interest
date	01/05/2024
answering body	Foreign, Commonwealth and Development Office
answering dept id	208
answering dept short name	Foreign, Commonwealth and Development Office
answering dept sort name	Foreign, Commonwealth and Development Office
hansard heading	International Seabed Authority
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what consideration they have given to nominating or supporting a specific candidate to be Secretary General of the International Seabed Authority.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4297
answer	answer is ministerial correction date of answer 16/05/2024 answer text <p>FCDO Ministers are considering the UK position in advance of the upcoming election for the Secretary-General of the International Seabed Authority. The question of mineral-resources related activities in the seabed beyond the limits of national jurisdiction for the benefit of humankind is a critical one, and we are therefore giving full consideration of all candidates for the election.</p> answering member printed Lord Benyon question first answered 16/05/2024 12:05:53 answering member 1547 label Biography information for Lord Benyon
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1715437

registered interest
date	01/05/2024
answering body	Department for Business and Trade
answering dept id	214
answering dept short name	Business and Trade
answering dept sort name	Business and Trade
hansard heading	Deep Sea Mining: Norway
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what discussions they have had with the government of Norway concerning that country's announcement that it will start exploratory deep seabed mining in its waters; and what assessment they have made of the impact this would have on wider North-eastern Atlantic fisheries.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4298
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The UK Government has not spoken to the Norwegian government about its decision of 9 January 2024 to consider awarding licences for deep sea mining exploration, and potentially future extraction, on its continental shelf but has taken note of the decision. This area is within Norway's jurisdiction and is not regulated by the International Seabed Authority.</p> answering member printed Lord Offord of Garvel question first answered 23/05/2024 17:01:37 answering member 4931 label Biography information for Lord Offord of Garvel
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1715438

registered interest
date	01/05/2024
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Deep Sea Mining: Environment Protection
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government when they intend to publish any reports from their newly launched environmental science network focusing on deep-sea mining, DSM Environmental Network.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4299
answer	answer is ministerial correction date of answer 10/05/2024 answer text <p>On 19 February, we opened the new UK Deep-Sea Mining (DSM) Environmental Science Network to applications. The aims of the network are to recognise and promote the extensive and world-renowned UK expertise in environmental and natural science related to DSM. The Network will not be responsible for developing policy or providing advice or recommendations to the Government or Ministers. Rather, it will help fill the current evidence gaps on the environmental impact of DSM, coordinate research effectively and strategically, make sure UK research is included in the global environmental evidence base for DSM, and encourage conversations between the Government and the scientific community to raise awareness and coordination between DSM science and policy environmental issues.</p> answering member printed Lord Benyon question first answered 10/05/2024 12:54:50 answering member 1547 label Biography information for Lord Benyon
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1715053

registered interest
date	30/04/2024
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Public Expenditure: Northern Ireland
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what discussions they have had with the Northern Ireland Executive, since the restoration of devolved institutions in Northern Ireland on 3 February, about financial allocations from the Treasury.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4234
answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The UK Government has regular discussions with its devolved administration counterparts, including the Northern Ireland Executive.</p><p> </p><p>Since the restoration of the Northern Ireland Executive, the Chief Secretary to the Treasury has met with the Northern Ireland Finance Minister on three occasions.</p><p> </p><p>UK Government officials continue to engage regularly with the Northern Ireland Executive on the implementation of all aspects of the UK Government’s £3.3 billion restoration financial package which will stabilise and transform Northern Ireland’s public finances.</p> answering member printed Baroness Vere of Norbiton question first answered 14/05/2024 14:06:13 answering member 4580 label Biography information for Baroness Vere of Norbiton
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick